Target intelligence / Profile preview

Selenoprotein F (SELENOF)

Target
SELENOF
Molecular classification
Selenoprotein, Redox enzyme, SEP15/Selenoprotein M family, Endoplasmic reticulum-resident protein, Thiol-disulfide isomerase (by sequence and domain similarity)
01

Overview

Selenoprotein F (SELENOF, also known as SEP15) is a 15 kDa selenoprotein found in most eukaryotes, localized within the endoplasmic reticulum. It contains the rare amino acid selenocysteine (encoded by UGA via a SECIS element) and is a member of the SEP15/Selenoprotein M protein family. SELENOF is thought to function primarily in the quality control of protein folding, partnering with the enzyme UDP-glucose:glycoprotein glucosyltransferase (UGGT1/UGGT2) and may act as a thiol-disulfide isomerase, facilitating proper disulfide bond formation. It contains a thioredoxin-like domain and a surface-accessible redox motif. SELENOF and its genetic locus are implicated in various cancers, including prostate and breast, with reduced expression associated with malignancy and certain cancer outcomes. Despite clear evidence for involvement in ER protein homeostasis and pathophysiological relevance, the precise molecular function and regulatory mechanisms of SELENOF are still being elucidated[2][3][1][5][7].

Other names
SEP1515 kDa selenoproteinSelenoprotein F (15 kDa)SELENOF
02

Biological functions

Redox reactions and disulfide bond formationQuality control of protein folding in the endoplasmic reticulumAssociation/regulation of glycoprotein glucosyltransferase (UGGT1/UGGT2)Possible involvement in cell signaling and tumor suppression
03

Disease associations

Cancer (including prostate and breast cancer)Keshan diseaseCongenital myopathy 3 with rigid spine
04

Safety considerations

Functional ambiguity—full systemic impact of SELENOF modulation is not clearly defined, posing challenges in clinical translationNo notable toxicity or safety signals listed in current search results
05

Biomarkers

Possible biomarker for cancer etiology, especially for prostate and breast cancer mortality risk—variants and reduction in protein levels have been associated with disease

Beyond the preview

Go deeper on Selenoprotein F (SELENOF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Selenoprotein F (SELENOF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call